Pancreatic Duct Relief with Stent

Unblocking Hope: How Stents Offer Relief for Chronic Pancreatitis

Nico Varela monogram
Nico Varela in Health & Wellness October 2026 • 4 min read.

"Discover how a specific type of pancreatic stent can effectively treat duct strictures and stones, improving the lives of those suffering from chronic pancreatitis."


Chronic pancreatitis is a persistent and often debilitating condition marked by inflammation and pain. This pain stems from increased pressure within the pancreatic ducts, frequently due to obstructions. Imagine a backed-up drain – that’s similar to what happens in the pancreas, leading to discomfort and a lower quality of life for many.

One promising solution is endoscopic pancreatic duct stenting. This involves placing a small tube (a stent) in the pancreatic duct to keep it open, allowing fluids to flow freely. While various types of stents exist, the 10Fr S-type plastic pancreatic stent has shown particular promise. This type of stent is designed to address both short-term and long-term relief from the pain associated with severe chronic pancreatitis.

A recent study investigated the effectiveness of these specific stents in patients with pancreatic duct strictures and stones. By understanding the outcomes, we can better assess the value of this treatment option for those battling chronic pancreatitis. The study aimed to provide insights into how these stents can improve patient outcomes and manage this challenging condition effectively.

AI Search Multiple angles on this topic

Clinical Outcomes and Long-Term Experience

Evidence summarized in a 2019 review indicates that, among patients with painful chronic pancreatitis and distal main pancreatic duct obstruction, treatment with a single stent was associated with better clinical outcomes than treatment with exclusively two stents during the stenting period. The review also describes main pancreatic duct strictures as a persistent challenge in chronic pancreatitis. Earlier long-term experience reported 11 years of plastic pancreatic stent use in 49 patients with chronic pancreatitis, all of whom had dominant strictures and duct dilation.

Endoscopic Drainage and Stent Selection

Therapeutic pancreatic stent placement is intended to restore the flow of pancreatic secretions when the duct has stenoses, leaks, fistulas, or anatomical malformations. Depending on the cause and clinical setting, physicians may use plastic stents or self-expandable metal stents. Endoscopic drainage for chronic pancreatitis can include sphincterotomy, stricture dilation, stone removal, and insertion of a plastic stent. The optimal treatment remains controversial among surgeons and endoscopists, and pancreatic stenting has recognized long-term safety and efficacy limitations.

An Evolving Endoscopic Approach

The development of pancreatic duct stenting represents a gradual shift toward endoscopic management of selected chronic pancreatitis complications. Over time, clinicians have refined techniques for duct drainage, stricture management, and stent selection. The historical record suggests continuing evolution rather than a single definitive breakthrough, with treatment choices still shaped by anatomy, symptoms, and procedural risks.

How Effective Are 10Fr S-Type Stents in Treating Chronic Pancreatitis?

Pancreatic Duct Relief with Stent

The study focused on 59 patients with chronic pancreatitis who underwent placement of 10Fr S-type pancreatic stents. These patients were closely monitored for over a year to evaluate the success of the stenting procedure. The process involved a few key steps, starting with confirming that the strictures weren't cancerous through cytology. Then, after gradually widening the pancreatic duct, the 10Fr stent was inserted.

To ensure continued effectiveness, the stents were replaced every three months. This regular exchange helped maintain the duct’s openness and prevent further blockages. The ultimate goal was to dilate the strictures sufficiently so the stents could eventually be removed. Regular monitoring and replacements were a cornerstone of the treatment protocol.

  • High Success Rate: Stents were successfully placed in 69.5% of patients (41 out of 59).
  • Significant Pain Relief: An impressive 90.2% (37 out of 41) of patients experienced relief from their pain.
  • Restenosis Rate: While effective, 41.5% (17 patients) experienced a recurrence of the duct stricture. However, restenting was successfully performed in 16 of these patients.
  • Cancer Monitoring: During the study, three patients (5.1%) developed pancreatic cancer, highlighting the importance of ongoing monitoring.
AI Search Multiple angles on this topic

New Evidence on Metal and Plastic Stents

Recent research continues to examine both the benefits and risks of pancreatic stenting in chronic pancreatitis. A 2024 study reported stent-induced ductal changes on pancreatography at removal in 52 of 223 patients with chronic pancreatitis who had an S-type plastic stent successfully placed for a duct stricture. A recent review describes fully covered self-expandable metal stents as offering superior patency, fewer reinterventions, and effective symptom relief compared with traditional plastic stents, while also identifying migration and de novo strictures as risks. Broader reviews continue to assess advances in the causes, mechanisms, diagnosis, and treatment of chronic pancreatitis.

Adverse Events and Repeat Procedures

Pancreatic plastic stents were introduced in the early 1980s for chronic pancreatitis-related duct strictures, but their use has since been accompanied by increasing reports of adverse events. Endoscopic pancreatic stenting can help prevent main pancreatic duct obstruction and relieve painful symptoms, yet the stent typically needs to be exchanged. The reported rate of adverse events is high, making follow-up and repeat intervention important limitations of this approach.

Comparing Stent Types in Fluid Collections

A 2024 network meta-analysis compared lumen-apposing metal stents, fully covered self-expandable metal stents, and double-pigtail stents for the management of pancreatic fluid collections. Its purpose was to identify which stent type may be most useful in that setting. Because the analysis addresses pancreatic fluid collections rather than all chronic pancreatitis duct strictures, its comparisons should not automatically be generalized to every stenting indication.

The study also pinpointed a critical factor affecting long-term success. Patients who still had remnant stones after the stenting treatment were significantly more likely to experience a recurrence of pancreatic duct strictures (p = 0.03). This highlights the importance of ensuring complete stone removal during the procedure to maintain the long-term benefits of stenting.

The Takeaway: A Promising Tool for Managing Chronic Pancreatitis

The study reinforces that using 10Fr S-type plastic pancreatic stents, with routine exchanges, is an effective strategy for managing chronic pancreatitis. It offers both short-term and long-term benefits for patients dealing with benign pancreatic duct strictures and impacted pancreatic stones, making it a valuable option in the fight against this challenging condition. Continuous research and improvements in stent technology promise even better outcomes for patients in the future.

AI Search Multiple angles on this topic

Balancing Relief and Risk

Taken together, the available evidence supports pancreatic stenting as a useful but selective endoscopic strategy for relieving duct-related problems in chronic pancreatitis. Its value must be weighed against migration, adverse events, duct changes, and the possibility of repeat procedures. Expert decision-making therefore remains dependent on the specific duct abnormality, the patient's symptoms, and the chosen stent type.

Long-Term Endoscopic Strategies

Future work is likely to focus on improving endoscopic treatment for a progressive disease marked by fibrosis, cellular infiltration, and loss of pancreatic parenchyma. One reported long-term study found that 74.4% of patients remained asymptomatic after stent removal, while 25.6% experienced recurrent pancreatitis or pancreatic-type pain during a mean follow-up of 9.5 years. Current approaches include duct decompression, resection, or combinations of both, with endoscopic intervention favored for its minimally invasive nature. These findings suggest continued interest in strategies that may provide durable relief beyond conventional single-plastic-stent treatment.

Complexity Beyond the Procedure

Chronic pancreatitis is a progressive condition, so the challenges surrounding stent treatment extend beyond the technical act of placement. Patients may require continuing assessment as symptoms, duct anatomy, and treatment needs change over time. This broader context favors individualized care and highlights why no single endoscopic strategy is likely to suit every patient.

Quality of Life and Symptom Relief

Pancreatic endotherapy offers a treatment option for chronic pancreatitis complications such as pancreatic duct strictures, stones, and pseudocysts. By addressing these duct-related problems, endotherapy is intended to reduce the clinical burden experienced by patients. Its real-world importance therefore extends beyond technical success to the potential effect on symptoms and quality of life.

Pain relief across different treatment comparisons

  • 43At follow-up, pain relief was reported by 32% of patients assigned to endoscopic drainage, compared with 75% assigned to surgical drainage, a 43-percentage-point difference favoring surgery (P=0.007).[1]
  • 91% and 92% pooled resolution ratesA meta-analysis of covered self-expandable metal stents reported pooled stricture resolution of 91% (95% CI, 85%–96%) and pain resolution of 92% (95% CI, 85%–98%).[2]

What the stent results can tell us

The high pain-relief proportion in the S-type report is encouraging, but the available figure alone does not establish how the result compares with other care or how durable the relief was.[3]

The drainage comparison points to different outcomes between endoscopic and surgical approaches in that comparison; it does not by itself establish which approach is preferable for every patient or setting.[1]

How other reports frame pancreatic duct stenting

The 10 Fr S-type evaluation was retrospective and included selected patients who had stent placement and follow-up beyond 12 months, so its findings describe that evaluated group rather than all people with chronic pancreatitis.[4]

Guideline context cited in the source supports 10 Fr plastic stents for severe strictures, while a separate review describes single plastic stenting as common but not uniformly effective, with resolution rates varying across reports.[2] [4]

The pooled metal-stent estimates concern covered self-expandable metal stents, a different stent category from the plastic S-type stent discussed in the article.[2] [4]

Sources

  1. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. (pubmed.ncbi.nlm.nih.gov)
  2. Covered self-expandable metal stents for pancreatic duct stricture: a systematic review and meta-analysis (pmc.ncbi.nlm.nih.gov)
  3. Efficacy of s-type stents for the treatment of the main pancreatic duct stricture in patients with chronic pancreatitis. (pubmed.ncbi.nlm.nih.gov)
  4. 10 Fr S-Type Plastic Pancreatic Stents in Chronic Pancreatitis Are Effective for the Treatment of Pancreatic Duct Strictures and Pancreatic Stones (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What exactly is a 10Fr S-type plastic pancreatic stent, and how does it work to relieve chronic pancreatitis symptoms?

A 10Fr S-type plastic pancreatic stent is a small tube inserted into the pancreatic duct to keep it open and allow fluids to flow freely. This specific type of stent is designed to provide both short-term and long-term relief from the pain associated with severe chronic pancreatitis caused by pancreatic duct strictures and stones. The "10Fr" refers to the stent's diameter, and the "S-type" describes its shape, which aids in its placement and stability within the duct.

2

Can you explain the process of endoscopic pancreatic duct stenting using a 10Fr S-type plastic pancreatic stent?

Endoscopic pancreatic duct stenting involves placing a 10Fr S-type plastic pancreatic stent into the pancreatic duct to alleviate obstructions. First, cytology confirms that the strictures aren't cancerous. Then, the pancreatic duct is gradually widened before the stent is inserted. To maintain effectiveness, the 10Fr S-type plastic pancreatic stents are replaced approximately every three months to ensure the duct remains open. The ultimate goal is to dilate the strictures sufficiently, so the stents can eventually be removed. Regular monitoring is critical.

3

Based on the study, what are the success rates and potential challenges associated with using 10Fr S-type plastic pancreatic stents for chronic pancreatitis?

The study demonstrated that 10Fr S-type plastic pancreatic stents can be effectively placed in a majority of patients, specifically around 69.5%. A significant portion of patients, approximately 90.2%, experienced relief from their pain. However, a notable percentage (41.5%) experienced a recurrence of the duct stricture, although restenting was often successful. It's also important to note that during the study, a small percentage of patients (5.1%) developed pancreatic cancer, highlighting the necessity for continued monitoring. Complete stone removal during the stenting procedure is crucial for long-term success.

4

What is restenosis, and what factors contribute to its occurrence after treatment with 10Fr S-type plastic pancreatic stents?

Restenosis, or the recurrence of duct strictures, can occur even after successful placement of 10Fr S-type plastic pancreatic stents. The study indicated a restenosis rate of 41.5%. However, restenting was successfully performed in most of these cases. One critical factor influencing restenosis is the presence of remnant stones after the initial stenting treatment. Patients with remnant stones were significantly more likely to experience a recurrence of pancreatic duct strictures. Therefore, complete stone removal during the procedure is essential to minimize the risk of restenosis.

5

Does the study compare 10Fr S-type plastic pancreatic stents to other treatments or stents available for chronic pancreatitis, and what are the implications of choosing one treatment over another?

While the study focused on the effectiveness of 10Fr S-type plastic pancreatic stents, other types of pancreatic stents exist, including different materials (e.g., metal stents) and designs. These alternative stents might offer different advantages or be more suitable for specific patient conditions. Additionally, the study doesn't cover other treatment modalities for chronic pancreatitis, such as pain management strategies, enzyme replacement therapy, or surgical interventions. These approaches may be used in conjunction with or as alternatives to stenting, depending on the individual patient's needs and the severity of their condition.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.